Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Verinata is driven by a sole, extraordinary purpose – maternal and fetal health. Our initial focus is to develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities using our proprietary technologies. We aim to reduce the anxiety associated with today's multi-step process, the unacceptable false-positive rates, the non-specific and sometimes confusing results of current prenatal screening methods, as well as the risk of current invasive procedures. In support of national guidelines recommending first trimester aneuploidy risk assessment, we believe women who desire such an assessment should be offered a single blood draw test with a definitive result. Verinata is conducting a prospective, blinded pivotal study to clinically validate the sensitivity and specificity of its first prenatal test on a large scale with results of the study expected in 2011.

BP SCI LLC distributes branded pipes, valves, and fittings. The company is headquartered in Dover, DE.

NIPD Genetics Ltd., part of Medicover AB, is a Cypriot company located in Nicosia that operates as biotechnology company. The firm was founded in 2010 by Philippos C. Patsalis, who is currently the CEO of the firm. On January 18, 2022 Medicover AB acquired NIPD Genetics Ltd. for $50.32 million.

Sequenom (NASDAQ: SQNM) is an American company based in San Diego, California. It develops enabling molecular technologies, and highly sensitive laboratory genetic tests for NIPT. Sequenom's wholly owned subsidiarity, Sequenom Center for Molecular Medicine (SCMM), offers multiple clinical molecular genetics tests to patients, including MaterniT21, plus a noninvasive prenatal test for trisomy 21, trisomy 18, and trisomy 13, and the SensiGene RHD Fetal RHD genotyping test.

Living MicroSystems develops a technology to select and analyze rare cells from the blood.

Shanghai Medusa Biotechnology Co., Ltd., established on 2021-07-20, Business scope includes general items:engaged in biology,Technical consulting in the field of medical technology,technology development,technology transfer,Technical Services(remove human stem cells,Gene diagnosis and medical technology development and application);Engineering and Technology Research and Experimental Development;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Production of Class I Medical Devices(limited branch);Production of Class II Medical Devices(limited branch);Production of Class III Medical Devices(limited branch);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Kodak Ltd. develops photographic, synthetic chemicals and photographic films. The company products include digital cameras, software, printers, accessories and picture CDs. Kodak is headquartered in Hemel Hempstead, UK.

Biolab is one of the 10 largest pharmaceutical companies in Brazil. The main characteristics about the trajectory is based on the commitment to offer health and quality of life to the Brazilian population. It is a market leader in Cardiology medicine prescriptions, vice-leader in the segment of Gynecology and acts with relevance in the areas of Dermatology, Orthopedics, Rheumatology and Pediatrics.

Gensignia Life Sciences, Inc. is an American private company located in San Diego, CA, with operations in the United Kingdom. The firm operates as a molecular diagnostics company which develop new molecular diagnosis techniques. It was founded by Gabriele Marco Antonio Cerrone.

Exponential Genomics, Inc. operates as a bio engineering company. It offers scaled genome editing, microfluidic cell handling and analysis, and biological databases. The company was founded by David Preiner, John Harrold, Sophie Ni, Ryan Hubbard and Dan Kriznic and is headquartered in Cambridge, MA.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Chongqing Jingyin Biotechnology Co., Ltd., established on 2013-11-04, Business scope includes licensed projects:Goods import and export business;engage in medical diagnosis and treatment activities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:gene technology,Research and development of genetic testing technology,technical consulting,Technical Services;Research and development of genetic testing instruments and supporting reagents,production and sales(Except for items requiring approval or permit).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

AVIVA Biosciences Corp. develops instrument platforms, consumables and biological assay systems. It leverages biochip micro technologies and has develops applications to serve unmet needs of the healthcare and life science industries. The company was founded by Julian Yuan and Jing Ching in 1999 and is headquartered in San Diego, CA.

Congenica is a biotechnology company that provides a diagnostic decision support platform. They have translated this research into the gold standard clinical genomic analytics platform, Sapientia, providing integration of human DNA sequences with deep clinical phenotyping, enabling clinicians to provide an actionable interpretation of genetic disease for patients. It was founded in 2013 and headquartered in Cambridge, Cambridgeshire.

Fluxion Biosciences was formed in 2005 to address critical needs for cellular analysis tools in the pharmaceutical, biotech and research industries. The company has developed a proprietary microfluidic platform which enables precise cellular manipulation, rapid low-volume compound addition, environmental control and software-based data acquisition.

Beijing Shuimuyuan Biotechnology Co., Ltd., established on 2013-04-26, The scope of business includes the sale of food;technology development,Technology Promotion,technical consulting,Technical Services,technology transfer;Selling Unprocessed Grains,unprocessed legumes,unprocessed potatoes,Packaged Seeds No Longer Divided,Stationery,crafts;Conference Services.(Enterprises independently choose operating projects according to law,Carry out business activities;Sale of food and items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.)

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. Its business scope ranges from scientific, health, agricultural and informatics. The company was founded by Wang Jian on September 9, 1999 and is headquartered in Shenzhen, China.